SCA
MEDP icon

Summit Creek Advisors’s Medpace MEDP Stock Holding History

Summit Creek Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
6,449
-5,796
-47% -$2.67M 1.16% 45
2026
Q1 		$5.88M Sell
12,245
-6,043
-33% -$3.09M 1.21% 43
2025
Q4 		$10.3M Sell
18,288
-15,934
-47% -$9.04M 1.62% 33
2025
Q3 		$17.6M Sell
34,222
-15,879
-32% -$6.93M 2.56% 8
2025
Q2 		$15.7M Sell
50,101
-2,131
-4% -$640K 2.19% 22
2025
Q1 		$15.9M Buy
52,232
+4,424
+9% +$1.49M 2.32% 19
2024
Q4 		$15.9M Buy
47,808
+146
+0.3% +$49.5K 2.09% 22
2024
Q3 		$15.9M Buy
47,662
+5,648
+13% +$2.15M 2.16% 20
2024
Q2 		$17.3M Sell
42,014
-6,842
-14% -$2.71M 2.37% 17
2024
Q1 		$19.7M Buy
48,856
+299
+0.6% +$105K 2.49% 14
2023
Q4 		$14.9M Buy
48,557
+25,510
+111% +$6.89M 1.99% 25
2023
Q3 		$5.58M Buy
+23,047
New +$5.89M 0.76% 46

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Summit Creek Advisors's MEDP Position: Q2 2026 in Review

Summit Creek Advisors reduced its Medpace (MEDP) stake by 47% in Q2 2026, selling an estimated $2.67M and leaving 6,449 shares worth $3.42M. The position accounts for 1.16% of the portfolio, ranked #45.

Summit Creek Advisors first reported a position in MEDP in Q3 2023 and has held it in 12 quarters since. The position peaked at $19.7M in Q1 2024. 608 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Summit Creek Advisors held 6,449 shares of Medpace worth $3.42M as of Q2 2026.
  • Summit Creek Advisors sold 5,796 Medpace shares in Q2 2026, an estimated $2.67M.
  • Medpace made up 1.16% of Summit Creek Advisors's portfolio in Q2 2026, its #45 holding.
  • Summit Creek Advisors first reported a position in Medpace in Q3 2023 and has held it in 12 quarters since.
  • Summit Creek Advisors's Medpace position peaked at $19.7M in Q1 2024.
  • 608 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Summit Creek Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.